New updates have been reported about Inspira Technologies.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Inspira Technologies has disclosed that it received a Nasdaq notice on February 9, 2026, indicating non-compliance with the exchange’s $1.00 minimum bid price rule after its ordinary shares traded below that threshold for 30 consecutive business days. The company’s stock will continue to trade on the Nasdaq Capital Market under the symbol IINN while Inspira has 180 calendar days, until August 10, 2026, to restore compliance by maintaining a closing bid of at least $1.00 for ten straight trading sessions.
If the company fails to regain compliance by that date, it may qualify for an additional 180-day grace period, subject to meeting all other initial Nasdaq Capital Market listing standards, including the market value of publicly held shares, and providing Nasdaq with a remediation plan that could include a reverse share split. Inspira plans to closely monitor its share price and evaluate available measures to address the deficiency, while continuing to advance its commercial-stage portfolio, including the FDA-cleared INSPIRA ART100 cardiopulmonary bypass system, the INSPIRA ART500 next-generation awake oxygenation platform, and its HYLA blood sensor technology.